Home > Press > Yissum Announces Nanotechnology for Increased Bioavailability of Compounds Wins Prestige Award
Yissum Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, today announced that Professor Nissim Garti from the Casali Institute of Applied Chemistry, Institute of Chemistry at the Hebrew University of Jerusalem has received the 2009 American Oil Chemists' Society (AOCS) Stephen S. Chang Award for his invention of novel nanoparticles of structured lipids to improve the bioavailability of various drug, food or cosmetic ingredients.
Yissum Announces Nanotechnology for Increased Bioavailability of Compounds Wins Prestige Award
Jerusalem, Israel | Posted on February 4th, 2009
"We are extremely proud that Professor Garti's achievements are recognized by the AOCS," stated Yehuda Yarmut, EVP and acting CEO of Yissum. His research is an excellent example of the importance and potential of basic research, and we believe that it has the potential to significantly improve the delivery of drugs, cosmetics and nutraceuticals."
Prof. Garti's inventions are based on trapping the relevant water-insoluble ingredient in a tiny liquid droplet. The nano-scale droplets function as microscopic shuttles, which deliver their cargo with increased efficiency. The technology could be utilized for delivering insoluble substances, for slow and controlled release of drugs, for improved transdermal drug delivery, and also for increased absorption of various food additives, such as in energy and health drinks. This technology has led to the establishment of NutraLease, a company that harnesses nano-encapsulation technology for improve delivery of drugs and nutraceuticals, such as vitamin D and E.
The latest development in Prof. Garti's work led to designing and constructing another set of new liquid architectures derived from lyotropic liquid crystals with cubic or hexagonal symmetries. The new delivery vehicles have water channels as well as oil channels that enable incorporation of water-soluble and oil-soluble bioactives for transdermal or transmembrane delivery. These novel preparations are thermodynamically stable and have very high solubilization capacities. They are designed to recognize the human membranes and to enhance the transport of the bioactives from the digestive tract to the blood stream or across the skin into the blood stream.
The Stephen S. Chang Award is bestowed by the AOCS in recognition of a scientist or technologist who has made decisive accomplishments in basic research that have been utilized by industries for the improvement or development of products related to lipids. The award winning ceremony will be part of the AOCS's 100th annual meeting, which will take place in Orlando, Florida on May 3-6.
About Yissum Ltd.
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. was founded in 1964 to protect the Hebrew University’s intellectual property and commercialise it. $1.2 Billion in annual sales are generated by products based on Hebrew University technologies licensed out by Yissum. Ranked among the top technology transfer companies in the world, Yissum has registered 6100 patents covering 1750 inventions; licensed out 480 technologies and spun out 65 companies. Yissum’s business partners span the globe and include companies such as Novartis, Microsoft, Johnson & Johnson, Merck, Intel, Teva and many more.
For more information, please click here
Copyright © Business Wire 2009
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
NREL Announces New Center Directors to lead R&D, Analysis Efforts September 30th, 2014
Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014
Speed at its limits September 30th, 2014
Research mimics brain cells to boost memory power September 30th, 2014
Park Systems Announces Outsourced Analytical Services Including AFM Surface Imaging, Data Analysis and Interpretation September 30th, 2014
Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014
Iranian Scientists Separate Zinc Ion at Low Concentrations September 20th, 2014
Nanoscience makes your wine better September 17th, 2014
Newly-Developed Nanosensor Controls Amount of Edible Dyes in Foodstuff Products September 5th, 2014
Iran Unveils 5 Home-Made Knowledge-Based Products August 25th, 2014
Sunblock poses potential hazard to sea life August 20th, 2014
AQUANOVA receives Technology Leadership Award 2014 FROST & SULLIVAN honors NovaSOL® Technology again August 12th, 2014
Nanotechnology used in sunscreens: a Mexican achievement May 14th, 2014
Production of Nanocapsule from Sea-Buckthorn Extract in Iran May 3rd, 2014
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014
Teijin Aramid’s carbon nanotube fibers awarded with Paul Schlack prize: New generation super fibers bring wave of innovations to fiber market September 25th, 2014
New chip promising for tumor-targeting research September 22nd, 2014
SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014